Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway
Cell Proliferation · 2026-11 · 59 (11)
DOI: 10.1111/cpr.70248 ↗At a glance
Journal article in Cell Proliferation, published online on 2026-06-10. Written by Yu Luo and 10 co-authors. Institution: Center of Regenerative Medicine and Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China. Major MEDLINE topics: PTEN Phosphohydrolase, Mouth Neoplasms, Dental Pulp, Stem Cells. Cited 1 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: State Key Project Ministry of Science and Technology of China, National Natural Science Foundation of China.
Abstract (original language)
Oral squamous cell carcinoma (OSCC) represents a globally predominant type of oral malignancy with escalating incidence, featuring aggressive biological behaviour, prominent metastatic potential and poor clinical outcomes. Emerging evidence positions dental pulp stem cell‐sourced intracellular vesicles (DPSC‐IVs) as novel therapeutic vectors in regenerative oncology, citing their low immunogenicity, favourable safety profile and ability to modulate tumour microenvironment. In this study, DPSC‐IVs significantly inhibited OSCC progression both in vitro and in vivo, suppressing tumour cell proliferation, invasion and colony formation while simultaneously promoting apoptosis. Notably, the antitumor effect of DPSC‐IVs was further enhanced by combining them with autophagy inhibitor 3‐methyladenine (3‐MA), which synergistically suppressed the PI3K/AKT/mTOR pathway and enhanced mitochondrial stress while suppressing residual cytoprotective autophagy. Mechanistically, DPSC‐IVs served as carriers of PTEN into OSCC cells, which in turn suppressed oncogenic PI3K/AKT signalling and induced excessive mitophagy. Taken together, this study indicated that DPSC‐IVs could suppress OSCC through dual mechanisms, highlighting their potential as a promising and clinically translatable therapeutic option with advantages in safety and scalable production.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center of Regenerative Medicine and Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China.
- Institute of Regenerative and Translational Medicine, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, China.
- Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID profiles: Yu Luo, Dongjie Fu
Funding
- State Key Project Ministry of Science and Technology of China
- National Natural Science Foundation of China
Cite
APA
Luo, Y., Qin, Q., She, W., Wang, X., Li, X., Shu, C., Li, R., Li, Z., Fu, D., He, Y., & Ye, Q. (2026). Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway. Cell Proliferation, 59(11). https://doi.org/10.1111/cpr.70248
Vancouver
Luo Y, Qin Q, She W, Wang X, Li X, Shu C, et al. Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway. Cell Proliferation. 2026;59(11). doi:10.1111/cpr.70248
BibTeX
@article{Luo2026,
author = {Luo, Yu and Qin, Qiang and She, Wenting and Wang, Xiangying and Li, Xiqin and Shu, Chenxuan and Li, Ruohan and Li, Ziwei and Fu, Dongjie and He, Yan and Ye, Qingsong},
title = {Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway},
journal = {Cell Proliferation},
year = {2026},
volume = {59},
number = {11},
doi = {10.1111/cpr.70248}
}
EUVIMED